Clinical Trial Update: Combination Chemotherapy in Treating Men With Germ Cell Cancer [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/Phase 3 clinical trial evaluating combination chemotherapy for men with germ cell tumors. The current status of the trial is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extragonadal Germ Cell Tumor
• Teratoma
• Testicular Germ Cell Tumor

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Extragonadal Germ Cell Tumor, Teratoma | Phase 2, Phase 3 | Status: UNKNOWN